Race against timeFirst the sell off started when the RS of this stock hit 80; RS over 70 is considered overbought and the sell off was brutal brought the stock from $ 5.90 down to $4 and lower. Money moved away from healthcare either off the market due to a recession scare or to utilities and health care large stocks. Small stocks were trashed.The sell off was purely on technical grounds and had nothing to do with fundamentals. Fundamentals play a role in price formation long term; short term the techs rule.Second, the stock is a price taker not price maker because it does not rely on its own product that can set the price n the market; it just follows the market on case rates to produce revenue and profits. The patent on its O'Regan system has expired two years ago though they are still marketing it. The stock in other words is caught between a rock and a hard place that is why it cannot increase profit margins. On the one hand reimbursement is set by the CMS on the other its expenses are set by market conditions, medical costs, wages and so forth. The company in other words is squeezed between two opposing forces the Government and the market. Third, being the case what it is, the company is forced to race against time in order to balance out these forces; it must generate volume as a way out of this impasse, and that will take time, lot of time. Volume will offset any CMS cuts and or increases in costs being it wages, or cost of acquisitions. Yes long run it might emerge victorious against all odds; but a lot of people want to meke money in the market before they die. GL